{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-029081","form_type":"8-K","ticker":"APYX","cik":"0000719135","company_name":"Apyx Medical Corp","filed_at":"2026-06-17T20:05:19+00:00","discovered_at":"2026-06-17T20:07:00.408876+00:00","generated_at":"2026-06-17T20:12:32.161589+00:00","sec_items":["1.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Apyx Medical appoints Chairman Stavros Vizirgianakis as Executive Chairman; grants 450,000 RSUs","bullets":["Stavros Vizirgianakis appointed Executive Chairman effective June 11, 2026; will lead strategic initiatives and investor engagement.","Receives 450,000 RSUs: 150,000 vest immediately, 150,000 over 12 months starting year 1, 150,000 over 12 months starting year 2.","No cash compensation for the role; only expense reimbursement.","Unvested RSUs fully accelerate upon a Change of Control.","Vizirgianakis will not be an officer or employee, nor designated as an executive officer."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-029081","json":"https://secwatch.observer/filing/0001493152-26-029081.json","markdown":"https://secwatch.observer/filing/0001493152-26-029081.md","text":"https://secwatch.observer/filing/0001493152-26-029081.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/719135/000149315226029081/0001493152-26-029081-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/719135/000149315226029081/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T20:12:32.161589+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}